Prospective, Open-Label, Multi-Center, Phase III Clinical Study To Investigate the Efficacy And Safety of Human Factor VWF/VIII Concentrate (Wilate)In Subjects With Inherited Type 3 Von Willebrand Disease (VWD) Who Undergo Major Surgical Procedures
|Effective start/end date||3/14/12 → 3/13/17|
- OCTAPHARMA USA, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.